# US 2025/0154128 A1 · A process for making osimertinib

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0154128 A1
- Document ID: US20250154128A1
- Status: Published application
- Kind: A1
- Application number: 18/686,210
- Filed: 2022-09-01
- Published: 2025-05-15
- Earliest claimed: 2021-09-02
- Assignees: Synthon BV
- Applicants: Synthon B.V.
- Inventors: Libor VYKLICKY; Miroslav ZABADAL
- Web page: https://patentgrep.com/patent/US20250154128A1

## CPC

- C07D 403/04: directly linked by a ring-member-to-ring-member bond
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The invention deals with a novel process for preparation of the pharmaceutically useful product Osimertinib of formula (1).

## Claims

### Claim 1

A process for preparing a compound of formula (1) or a salt thereof,
which comprises:
a) reacting a compound of formula (2) with hydrazine or ammonium formate in the presence of a catalyst in a solvent to obtain a compound of formula (3),
and
b) transforming the compound of formula (3) into the compound of formula (1).

### Claim 2 (depends on 1)

The process according to claim 1 wherein the catalyst is selected from Pd or Pt or Fe or Ru or Rh

### Claim 3 (depends on 2)

The process according to claim 2 wherein the catalyst is selected from Pd or Pt or Fe.

### Claim 4 (depends on 3)

The process according to claim 3 wherein the catalyst is selected from Pd or Pt.

### Claim 5 (depends on 4)

The process according to claim 4 wherein the catalyst is selected from Pd/C or Pt/C.

### Claim 6 (depends on 1)

The process according to claim 1 wherein hydrazine is hydrazine hydrate.

### Claim 7 (depends on 1)

The process according to claim 1 wherein the molar ratio between the compound of formula (2) and hydrazine or ammonium formate is between 1:3 and 1:20.

### Claim 8 (depends on 7)

The process according to claim 7 wherein the ratio is between 1:10 and 1:15.

### Claim 9 (depends on 1)

The process according to claim 1 wherein the solvent is selected from 2-methyl tetrahydrofuran or dioxane or tetrahydrofuran or an alcohol or dimethylformamide.

### Claim 10 (depends on 9)

The process according to claim 9 wherein the alcohol is selected from methanol or ethanol or propanol.

### Claim 11 (depends on 1)

The process according to claim 1 wherein the transforming of the compound of formula (3) into the compound of formula (1) comprises:
a) reacting the compound of formula (3) with a compound of formula (4),
wherein Hal represents Cl or Br; or
b) reacting the compound of formula (3) with a compound of formula (5) to obtain a compound of formula (6) and transforming the compound of formula (6) into the compound of formula (1),
wherein Hal represents Cl or Br.

### Claim 12 (depends on 11)

The process according to claim 11 wherein the compound of formula (1) is transformed to a salt.

### Claim 13 (depends on 12)

The process according to claim 12 wherein the salt is methane sulfonate salt.
